Study Evaluating Enbrel (Etanercept) in Adult Patients With Plaque Psoriasis

Pfizer753 enrolled

Overview

The purpose of this study is to investigate the incidences of adverse events for patients with plaque psoriasis treated with Enbrel under usual care settings.

Study Type

OBSERVATIONAL

Enrollment

753

Conditions

Plaque Psoriasis

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Proven diagnosis of Plaque Psoriasis Exclusion Criteria: * Contraindications according to SmPC of Enbrel

Locations (2)

Pfizer Investigational Site

Munich, Germany

Pfizer Investigational Site

München, Germany

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.